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Viral infection activates cytokine expression and trig-
gers cell death, the modulation of which is important
for successful pathogenesis. Necroptosis is a form
of programmed necrosis dependent on two related
RIP homotypic interaction motif (RHIM)-containing
signaling adaptors, receptor-interacting protein
kinases (RIP) 1 and 3. We find that murine cytomeg-
alovirus infection induces RIP3-dependent necrosis.
Whereas RIP3 kinase activity and RHIM-dependent
interactions control virus-associated necrosis,
virus-induced death proceeds independently of
RIP1 and is therefore distinct from TNFa-dependent
necroptosis. Viral M45-encoded inhibitor of RIP acti-
vation (vIRA) targets RIP3 during infection and
disrupts RIP3-RIP1 interactions characteristic of
TNFa-induced necroptosis, thereby suppressing
both death pathways. Importantly, attenuation of
vIRA mutant virus in wild-type mice is normalized in
RIP3-deficient mice. Thus, vIRA function validates
necrosis as central to host defense against viral
infections and highlights the benefit of multiple
virus-encoded cell-death suppressors that inhibit
not only apoptotic, but also necrotic mechanisms
of virus clearance.
INTRODUCTION
Cellular sensing of viral pathogens by the host activates inflam-
matory gene expression and triggers cell death. These distinct
cell-intrinsic response pathways directly control viral spread
from the portal of entry and influence the quality of pathogen-
specific adaptive immunity. Innate antiviral cytokines such as
interferon (IFN) have long been considered central to control of
viral spread (Roy and Mocarski, 2007), with caspase-dependent
apoptotic cell death viewed as a complementary, evolutionarily
conserved clearance mechanism triggered by distinct signals.
The importance of death has been reinforced by the widespread
existence of apoptotic cell-death suppressors, including those
that viruses employ to subvert intrinsic clearance. These include
(1) caspase inhibitors, such as baculovirus p35 (Clem et al.,
1991), viral inhibitors of apoptosis (Crook et al., 1993), poxvirus
crmA (Ray et al., 1992), and viral FLICE (caspase-8) inhibitory
proteins (Thome et al., 1997), as well as (2) mitochondrial cell-
death suppressors such as viral Bcl-2 homologs and other302 Cell Host & Microbe 7, 302–313, April 22, 2010 ª2010 Elsevier Inproteins encoded by large DNA viruses that block cytochrome
c release from mitochondria (Galluzzi et al., 2008). Although
apoptosis is a well-established cell-intrinsic response to patho-
gens, caspase-independent cell death, or programmed necro-
sis, has emerged as an alternative death pathway that dominates
under specific conditions (Festjens et al., 2006). Necroptosis is
a form of programmed necrosis induced by death receptors
(DR) that is independent of caspases but dependent on
receptor-interacting protein kinase (PK) 1 (RIP1) (Festjens
et al., 2007; Meylan and Tschopp, 2005) and RIP3 (Cho et al.,
2009; He et al., 2009; Zhang et al., 2009), two related RIP homo-
typic interaction motif (RHIM) -containing signaling adaptors
(Sun et al., 2002). Necroptosis has been viewed as an alternative
to apoptosis, and is triggered by the same signals under condi-
tions where caspase-8 activation has been suppressed or is
absent (Festjens et al., 2007). This alternative death pathway
could come into play as a host countermeasure against invading
pathogens (Cho et al., 2009); however, evidence that this
pathway is suppressed by any microbe for pathogenesis
in vivo has not yet been revealed.
RIP1 is the founding member of a serine-threonine PK family
that transduces inflammatory and cell-death signals following
DR ligation, activation of pattern recognition receptors (PRRs),
and DNA damage (Festjens et al., 2007). An amino-terminal PK
domain in RIP1 is critical for DR-induced necroptosis (Holler
et al., 2000) and is the target of the inhibitor necrostatin-1
(Nec-1) (Degterev et al., 2008). RIP1 has a carboxy-terminal
death domain (DD) that engages other DD-containing proteins
as well as a central (intermediate) domain important for NF-kB
activation (Festjens et al., 2007) and RHIM-dependent signaling
(Sun et al., 2002). Three other cellular RHIM-containing adaptors
interact with RIP1 to initiate gene activation and cell death: (1)
RIP3, the only other RHIM-containing RIP family member (Sun
et al., 2002), (2) the Toll-like receptor (TLR) 3 and TLR4 adaptor
TIR domain-containing adaptor-inducing IFNb (TRIF) (Kaiser
and Offermann, 2005; Meylan et al., 2004), and (3) DNA-depen-
dent activator of IFN-regulatory factors (DAI, also termed DLM-1
or ZBP1) (Kaiser et al., 2008; Rebsamen et al., 2009), a candidate
DNA sensor (Takaoka et al., 2007). Thus, RIP1 is a central
adaptor, balancing inflammatory cytokine activation as well as
the initiation of programmed cell-death pathways.
When first evaluated, RIP3 appeared to exert a negative
modulatory role in TLR3- or DR-dependent NF-kB activation
(Meylan et al., 2004; Sun et al., 2002). More recently, RIP3 has
been shown to have a positive impact on DAI-induced, RIP1
RHIM-dependent NF-kB activation (Kaiser et al., 2008; Rebsa-
men et al., 2009), as well as in RHIM-dependent necroptosis
induced by TNFa (Cho et al., 2009; He et al., 2009; Zhang
et al., 2009). The requirement for caspase inhibition to unveilc.
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dent necroptosis in natural biological settings (Declercq et al.,
2009). Whereas mice lacking RIP1 die within 3 days postnatally
(Kelliher et al., 1998), RIP3-deficient mice are viable and display
neither developmental defects nor altered NF-kB signaling trig-
gered by lipopolysaccharide (LPS) or TNFa (Newton et al.,
2004). One recent report described a decrease in inflammatory
liver pathology in vaccinia virus-infected RIP3-deficient mice,
processes that were ascribed to altered TNFa-induced necrop-
tosis (Cho et al., 2009).
Human cytomegalovirus (HCMV), the prototypic, medically
significant b-herpesvirus, and murine cytomegalovirus (MCMV),
a surrogate used to model viral pathogenesis, encode several
cell-death suppressors (McCormick, 2008). TheMCMVM45-en-
coded viral inhibitor of RIP activation (vIRA) is a viral structural
protein (Lembo et al., 2004) originally identified as a tropism
determinant required for endothelial cell-specific viral replication
(Brune et al., 2001). MCMV mutants lacking vIRA induce prema-
ture death in some cell lines, although the mechanism of death
remains unresolved. Caspase-dependent and -independent
cell-death pathways have been implicated (Brune et al., 2001;
Mack et al., 2008). Recent reports showing the critical role of
RIP1 and RIP3 in DR-induced necroptosis (Cho et al., 2009; He
et al., 2009; Zhang et al., 2009), together with previous evidence
that vIRA physically interacts efficiently with RIP3 as well as RIP1
(Uptonet al., 2008), suggest that vIRAmay interactwithRIP3and/
orRIP1 to suppress cell death in sensitive cell types; however, the
specific contributions of these adaptors to the mutant virus
phenotype have not been established. Here we demonstrate
that vIRA disrupts formation of a RHIM-dependent RIP3-RIP1
kinase complex in TNFa-induced necroptosis as well as a RIP3
RHIM-dependent, RIP1-independent step in virus-induced
necrosis. Importantly, the severe attenuation of vIRA-deficient
virus is normalized in mice that lack RIP3 function. Thus, RIP3
mediates necrotic death independently of RIP1, and viral
suppression of RIP3 provides a benefit during viral pathogenesis.
RESULTS
vIRA RHIM-Dependent Interactions Are Necessary
for Suppression of Virus-Induced Programmed Necrosis
during Pathogenesis
To explore the biological consequences of vIRA RHIM-specific
interactions during infection, a recombinant mutant MCMV was
evaluated in cells and animals. M45mutRHIM virus carried
a substitution mutation (see Figures S1A and S1B available
online) previously shown to disrupt RHIM-dependent interac-
tions (Upton et al., 2008). Viral stocks were recovered from
transfected NIH 3T3 fibroblasts with mutant and parental viruses
exhibiting equivalent replication properties, as elaborated previ-
ously (Brune et al., 2001). Viral genome integrity was affirmed by
restriction enzyme digestion (Figure S1C; data not shown).
Immunoblot analysis indicated M45mutRHIM and parental
viruses produced M45 proteins of comparable size and levels
of expression (Figure 1A). Infected cells also expressed similar
levels of viral immediate early (IE) 1 protein. To investigate
whether the in vivo behavior of vIRA mutant virus recapitulated
the severe attenuation previously demonstrated for vIRA null
mutants (Lembo et al., 2004), we evaluated mutant and parentalCellvirus replication in immunodeficient and immunocompetent
mice. To evaluate viral replication, dissemination, and virulence
independently of innate natural killer (NK) as well as adaptive T
and B lymphocyte function, the behavior of these viruses was
compared in nonobese diabetic (NOD), severe combined immu-
nodeficient (scid), IL2 common g chain/ (NSG) mice (Shultz
et al., 2005). Mutant virus exhibited 103-fold reduced levels in
spleen, 104-fold reduced levels in liver, and 106-fold reduced
levels in salivary glands (SGs) compared with parental virus
(Figure 1B). To investigate viral pathogenesis, cohorts of NSG
mice inoculated with either virus were followed for 6 weeks.
Whereas mice infected with parental virus succumbed between
20 and 22 days postinfection, mutant virus-infected animals
showed no signs of CMV disease up to 42 days (Figure 1C)
and beyond (data not shown). We extended in vivo studies to
include immunocompetent mice, demonstrating that parental
virus was detected in the spleens of BALB/c mice by day 3 post-
inoculation when virus titers normally peak (Figure 1D) whereas
mutant virus remained undetectable at this time (Figure 1D) as
well as at day 5 (data not shown). The phenotype of M45mutR-
HIM mutant virus was similar to previously characterized
vIRA-deficient viruses (Lembo et al., 2004). Importantly, the
attenuated phenotype of M45mutRHIM in vivo establishes the
critical role of RHIM-dependent interactions in vIRA function,
extending prior investigations that relied upon truncation or dele-
tion mutants that eliminated vIRA expression, and demonstrates
the significance of RHIM-dependent signaling in antiviral host
defense.
Consistent with prior reports using vIRA null mutants (Brune
et al., 2001; Mack et al., 2008; Upton et al., 2008), M45mutRHIM
virus was severely attenuated for growth in SVEC4-10 cells
(Figure 1E), which died within 18 hr after exposure to mutant
(Figure 1F). Parental virus replicated at levels similar to NIH
3T3 cells, where there was no impact on cell viability, and unin-
fected NIH 3T3 fibroblasts were sensitive to TNFa-induced
apoptosis. As expected from previous investigations (Mack
et al., 2008), mutant virus-induced cell death was unaffected
by addition of the caspase inhibitor zVAD-fmk (Figure 1F). Addi-
tionally, the phenotype of two independently derived M45mutR-
HIM isolates was comparable (Figure S2A). Thus, the behavior of
RHIMmutant virus recapitulates that of previously characterized
M45-deficient viruses, and clearly demonstrates that RHIM-
dependent interactions are central to vIRA-mediated cell-death
suppression, consistent with a model (Upton et al., 2008) impli-
cating a RHIM-dependent interaction(s) in control of an antiviral
cell-death pathway triggered by infection. Thus, MCMV induces
programmed caspase-independent death in susceptible cells,
and virus-encoded vIRA naturally suppresses this pathway by
interfering with RHIM-dependent pathways.
Given initial observations on vIRA as an endothelial growth
determinant (Brune et al., 2001), we were surprised when
M45mutRHIM virus replicated poorly (Figure 2A) and induced
premature death in 3T3-Swiss albino (3T3-SA) fibroblasts (Fig-
ure S2A), another immortal cell line fully permissive for parental
MCMV (Figure S2B; data not shown). Exposure to mutant virus
resulted in premature death comparable to SVEC4-10 cells,
based on three independent lines of evidence: morphological
evaluation (Figure 2B; Figure S2), intracellular ATP levels
(Figure 2C), and release of intracellular proteases (Figure 2D).Host & Microbe 7, 302–313, April 22, 2010 ª2010 Elsevier Inc. 303
Figure 1. Role of MCMV M45 RHIM Interactions in Suppression of Virus-Induced Death
(A) IB analysis of vIRA expression from recombinant viruses to detect vIRA (M45), IE1, and b-actin. NIH 3T3 fibroblasts were either mock or virus infected at a
multiplicity of infection (MOI) of 10 with bacmid-derived K181 (WT) or vIRA mutant virus (M45mutRHIM). An asterisk (*) designates a second independent WT or
mutant virus isolate.
(B) Replication levels and pathogenesis of parental WT and M45mutRHIM virus in severely immunodeficient NSG mice. At 16 days postinoculation (106 pfu
into footpads), spleen (left), liver (middle), and SGs (right) were harvested from euthanized mice and viral titers were determined by plaque assay. Each symbol
represents one animal, solid horizontal lines represent the mean for each group, and dashed lines indicate the limit of detection in each assay.
(C) Kaplan-Meier survival plot of NSG mice monitored for 42 days postinfection with parental WT and M45mutRHIM virus (106 pfu into footpads).
(D) Replication levels of parental WT and M45mutRHIM virus in spleen at 3 days postinoculation (106 pfu into peritoneal cavity) of BALB/c mice.
(E) Replication levels of parental WT andM45mutRHIM virus in infected NIH 3T3 fibroblasts (left) and SVEC4-10 endothelial cells (right) (MOI = 10). Viral titers were
determined by plaque assay at the indicated times postinfection.
(F) Viability of NIH 3T3 fibroblasts (left) or SVEC4-10 cells (right) following infection with parental WT and M45mutRHIM virus. Where noted, zVAD-fmk (50 mM)
was included throughout infection. Cell viability was determined by measuring intracellular ATP levels with a Cell Titer-Glo Luminescent Cell Viability Assay kit.
Treatment with TNFa (25 ng/ml) and cycloheximide (CHX; 5 mg/ml) was used to induce apoptosis in uninfected NIH 3T3 cells as a control. Error bars indicate
standard deviation (SD) of the mean.
See also related Figure S1.
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9 hr postinfection (hpi) and approachedmaximal levels by 18 hpi.
Death was accompanied by cytoplasmic swelling, cell detach-
ment, propidium iodide inclusion, and membrane rupture
(Figure S2C; data not shown), morphological evidence most
consistent with necrosis (Festjens et al., 2006). To demonstrate
that the collapse in ATP levels (Figure 2C) was due to necrotic
death and not to viral modulation of cellular respiration, we
showed intracellular proteases were released into the culture
medium (Figure 2D), consistent with loss of plasma membrane
integrity, rather than changes in cellular physiology during infec-
tion. In contrast, when TNFa plus cycloheximide (CHX) was
employed to induce apoptosis, ATP levels decreased without304 Cell Host & Microbe 7, 302–313, April 22, 2010 ª2010 Elsevier Ina dramatic rise in extracellular protease activity. To assure that
the virus-induced cell death occurred independently of apo-
ptosis or autophagy, infected cells failed to exhibit evidence of
caspase-3 activation at any time from 6 through 18 hpi with
mutant virus, and levels of LC3 II in virus-infected cells remained
similar to uninfected cells and lower than Bafilomycin A1-treated
controls (Figure 2E). Ultrastructural analysis by electron micros-
copy (EM) revealed no evidence of membrane blebbing, nuclear
condensation, or autophagosome formation in mutant-infected
cells compared with wild-type (WT) virus infection (Figure 2F;
data not shown). Taken together, these observations were
most consistent with induction of programmed necrosis during
mutant virus infection.c.
Figure 2. Cells Sensitive to MCMV-Associated Programmed Necrosis Express High Levels of RIP3
(A) Viral yields determined by plaque assay at 72 hpi in 3T3-SA cells following infection with parental WT or M45mutRHIM virus (MOI = 10).
(B) Bright-field micrographs of 3T3-SA cells infected for 18 hr with either parental WT (left) or M45mutRHIM (right) virus. Magnification, 103.
(C) Viability of 3T3-SA cells assessed by intracellular ATP levels following infection with parental WT or M45mutRHIM virus.
(D) Release of protease to the medium assessed in 3T3-SA cells using a CytoTox-Fluor Assay kit.
(E) IB of 3T3-SA cells infected with parental WT or M45mutRHIM virus (MOI = 10) for the indicated times followed by detection of IE1, caspase-3, LC3 II, and
b-actin. The vertical line shows where lanes from the original gel were brought adjacent. In (C)–(E), uninfected cells were treated to induce apoptosis (TNFa/CHX)
as described in Figure 1F or with Bafilomycin A1 (250 nM) to induce LC3 II, or left untreated.
(F) Transmission electron micrographs of 3T3-SA cells at 18 hpi with WT (top) or M45mutRHIM (bottom) virus. Scale bars are indicated.
(G) IB analysis of NIH 3T3, 3T3-SA, and SVEC4-10 cells to detect RIP1, RIP3, and b-actin.
(H) Viability of NIH 3T3, 3T3-SA, and SVEC4-10 cells treated for 18 hr with TNFa (25 ng/ml) in the absence or presence of zVAD-fmk (25 mM).
Error bars indicate SD of the mean. See also related Figure S2.
Cell Host & Microbe
Virus Inhibition of RIP3-Dependent NecrosisAs recent studies have implicated high levels of RIP3 as a
determinant in necroptosis (Cho et al., 2009; He et al., 2009;
Zhang et al., 2009), we evaluated levels of known vIRA-inter-
acting proteins, RIP1 and RIP3, in susceptible cells (3T3-SA
and SVEC4-10). Immunoblot (IB) analysis revealed RIP3 levels
were elevated compared with NIH 3T3 controls (Figure 2G),
whereas RIP1 levels were similar in all cell lines. SVEC4-10
and 3T3-SA cells were sensitive to DR-induced necroptosis
(Figure 2H), paralleling susceptibility to virus-induced pro-
grammed necrosis. Thus, high levels of RIP3 are a defining
characteristic of cells sensitive to either form of necrotic death,
implicating this adaptor in necrosis induced by different
stimuli.CellvIRA Suppresses Necroptosis in a RHIM-Dependent
Fashion
To establish the contribution of RIP1 and RIP3 to necroptosis
in SVEC4-10 and 3T3-SA cells, we employed specific shRNAs
(RIP3-A and RIP3-B) to reduce expression levels of RIP3.
This RNAi approach showed RIP3 played a critical role in
TNFa-induced necroptosis (Figures 3A and 3B). Addition of the
RIP1 kinase inhibitor Nec-1 restored cell viability, showing nec-
roptosis to be RIP1 kinase dependent (Figure 3B; Figures S3E
and S3F) (Degterev et al., 2008). The contribution of RIP3 and
RIP1 to necroptosis was further evaluated inRIP1/ and control
RIP1+/+ mouse embryonic fibroblasts (MEFs). RIP1/ MEFs
were insensitive to necroptosis (Figure 3C), but, as expectedHost & Microbe 7, 302–313, April 22, 2010 ª2010 Elsevier Inc. 305
Figure 3. MCMV RHIM-Dependent Suppression of RIP3-Mediated Necrosis
(A) IB analysis (top) to detect RIP3, RIP1, and b-actin, and viability (bottom) of 3T3-SA fibroblasts expressing a scramble control (Sc) or one of two RIP3-specific
shRNAs (RIP3-A and RIP3-B) and treated to induce necroptosis as described in Figure 2H or to induce apoptosis as described in Figure 1F.
(B) IB analysis (top) to detect RIP1, RIP3, and b-actin, and viability (bottom) of SVEC4-10 cells expressing Sc or RIP3-A shRNA. Cells were treated to induce
necroptosis as described in Figure 2H in the absence or presence of Nec-1 (30 mM).
(C) Viability (top) and IB analysis to detect RIP1, RIP3, b-actin, and Flag-epitope-tagged proteins (bottom) in RIP1+/+ and RIP1/MEFs transduced with empty
vector (EV), Flag-tagged RIP3 (RIP3), or Flag-tagged kinase-deficient RIP3 (RIP3-KD) retroviral constructs. Transduced cells were treated as described in (B).
The vertical line shows where lanes from the original gel were brought adjacent.
(D) IB of myc-tagged proteins following IP with anti-myc-conjugated agarose (top) of SVEC4-10 cells transduced with EV, M45-myc, or M45mutRHIM-myc
retroviral constructs, and viability (bottom) of these cells after treatment as described in (B).
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sensitivity to TNFa-induced apoptosis (Figure 3C). IB analysis
of empty vector (EV) transduced RIP1/ and control MEFs
showed similar expression of endogenous RIP3 (Figure 3C). To
evaluate the impact of increasing RIP3 in the absence of RIP1,
RIP1/ and control MEFs were transducedwith epitope-tagged
WT or kinase-deficient (KD) RIP3 (Figure 3C, bottom). Elevated
levels of WT, but not KD, RIP3 conferred increased sensitivity
of WT MEFs to TNFa plus zVAD-fmk-induced necroptosis
(Figure 3C). This was shown also to be dependent on RIP1
kinase activity using Nec-1. In contrast, overexpression of
RIP3 in RIP1/ MEFs failed to enhance susceptibility to either
necroptosis or apoptosis. Interestingly, elevated expression of
RIP3, but not RIP3-KD, in RIP1/ MEFs resulted in a dramatic
RIP3 mobility shift, suggesting RIP1 may suppress a RIP3
kinase-dependent posttranslational modification of RIP3
(Figure 3C). Together, these results indicate that RIP1 plays an
essential role in induction of DR-associated necrotic death,
elevated levels of RIP3 are necessary for this pathway, and over-
expression of RIP3 cannot overcome the requirement for RIP1 in
DR-induced cell death. Furthermore, these data establish that
the PK activity of both RIP1 and RIP3 is required in necrotic
death induced following DR activation in sensitive cells. These
independently derived results reaffirm the essential role of an
active RIP3-RIP1 kinase complex to drive DR-induced necropto-
sis (Cho et al., 2009; He et al., 2009; Zhang et al., 2009).
To investigate the role of the vIRA RHIM in suppression of nec-
roptosis, SVEC4-10 cells stably expressing epitope-tagged WT
(M45-myc) or mutant (M45mutRHIM-myc) vIRA were generated
(Figure 3D) and compared to cells carrying an EV as control. As
expected, expression of WT vIRA conferred protection to treat-
ment with TNFa plus zVAD-fmk (Figure 3D) (Mack et al., 2008).
Cells expressing M45mutRHIM-myc were as sensitive to death
as control cells, indicating vIRA is a potent RHIM-dependent
suppressor of necroptosis. Because both RIP1 and RIP3
contributed to the necroptotic pathway (Cho et al., 2009; He
et al., 2009; Zhang et al., 2009), we sought to evaluate the poten-
tial role of vIRA as a competitor of RIP1-RIP3 complex formation.
Flag-RIP3 and myc-RIP1 were coexpressed in 293T cells in the
presence of increasing amounts of either WT M45-Flag or
mutant M45mutRHIM-Flag. Immunoprecipitation (IP) followed
by IB analysis revealed a RHIM-dependent vIRA-mediated inhi-
bition of RIP1-RIP3 complex formation (Figure 3E). This demon-
stration provides mechanistic insight into how vIRA suppresses
the execution of necroptosis initiated by DR signaling but leaves
open whether RIP1, RIP3, or both are directly bound by the viral
cell-death suppressor.
MCMV-Induced Programmed Necrosis Is RIP3
Dependent but RIP1 Independent
Having shown vIRA suppresses RIP1/3-dependent necroptosis,
we characterized the cellular requirements for MCMV-associ-
ated programmed necrosis. RIP3 knockdown rendered either
3T3-SA or SVEC4-10 cells resistant to virus-induced pro-(E) IB of 293T cells transfected with Flag-tagged RIP3, myc-tagged RIP1, and 1, 2
with anti-myc agarose beads. In all samples, the amount of transfected DNA w
anti-Flag or anti-c-myc (9E10) antibody. Major protein species are identified, wit
Error bars indicate SD of the mean.
Cellgrammed necrosis (Figures 4A and 4B). To clarify the role of
RIP3, control (RIP3+/+), heterozygous (RIP3+/), and homozy-
gous (RIP3/) deficient MEF cells were isolated and assessed
for virus replication and sensitivity to programmed necrosis.
RIP3 levels in cells reflected gene copy (Figure 4D). Parental
MCMV replicated to comparable high titers in all MEF lines
tested, whereas M45mutRHIM virus was attenuated in RIP3+/+
cells (Figure 4E), where RIP3 levels were highest (Figure 4D),
and normalized in RIP3/ MEFs (Figure 4E). Consistent with a
relationship betweenRIP3 levels and sensitivity to necrotic death
(Figure 4D), the mutant virus phenotype was intermediate in
RIP3+/ cells (Figures 4E and 4G). Furthermore, RIP3+/+ MEFs
died following mutant virus infection, whereas RIP3/ cells
survived, sustaining the requirement for RIP3 in virus-induced
death (Figure 4G). RIP3 levels correlated with cellular sensitivity
to virus-induced programmed necrosis as well as to the
concomitant attenuation of viral growth. When RIP3/ MEFs
were reconstituted with WT, KD, or mutant RHIM (mRHIM)
RIP3 (Figure 4F) and infectedwithmutant virus, onlyWTRIP3-re-
constituted cells exhibited increased sensitivity to virus-induced
necrosis (Figure 4F). These data are consistent with a direct role
of RIP3 as well as a requirement for an intact RIP3 kinase domain
and RHIM for virus-induced necrotic cell death.
To formally demonstrate that vIRA directly targets RIP3 to
modulate this death process during infection, we infected
necrosis-sensitive 3T3-SA cells. M45 protein interacted with
RIP3 but not mutRHIM M45 protein when infected cell lysates
were subjected to co-IP at 12 and 18 hpi with antibody to RIP3,
consistent with a RHIM-dependent interaction of vIRA with
endogenous RIP3 (Figure 4C). Wewere unable to detect an inter-
action between endogenous RIP3 and RIP1 during viral infection
witheitherWTormutant viruses (datanot shown), suggesting that
virus-associated programmed necrosis makes distinct use of
adaptors comparedwith DR-induced necroptosis. To investigate
the role of TNFa as well as RIP1 in virus-associated programmed
necrosis, infected cells were treated with TNFa-neutralizing anti-
body over a range of effective concentrations (Figure S3D)
without observing any impact on virus-induced necrosis (Figures
S3A–S3C). Infected cells were also treatedwith the RIP1-specific
kinase inhibitor Nec-1 to determine whether RIP1 kinase activity
contributes to virus-induced programmed necrosis. Treatment
with Nec-1 over a range of doses failed to restore viability of
infected primary MEF, 3T3-SA, or SVEC4-10 cells (Figure 4G,
gray bars; Figures S3E–S3G). In contrast, Nec-1 treatment was
sufficient to suppress TNFa-induced necroptosis in these same
cell lines (Figure 4G; Figures S3E and S3F), confirming both the
sensitivity of these cells to necroptosis and the efficacy of Nec-
1 as a RIP1 inhibitor when this adaptor is involved in death.
Thus, RIP1 kinase activity is dispensable for virus-associated
programmed necrosis, in contrast to its critical role in necropto-
sis. Because SV40-transformed MEFs, including both the
RIP1+/+ and RIP1/ MEFs used in Figure 3C, were resistant to
virus-inducedcell death (datanot shown),weemployedanumber
of different hairpin RNAi constructs to suppress RIP1 in primary, or 4 mg of either M45-Flag or M45mutRHIM-Flag expression plasmids after IP
as held constant with addition of control plasmid DNA. IB detection was with
h ‘‘cp’’ indicating a processed form of RIP1 or RIP3.
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Figure 4. RIP3 Is Required, and RIP1 Is Dispensable, for MCMV-Associated Programmed Necrosis
(A) Viability of 3T3-SA cells expressing Sc, RIP3-A, or RIP3-B shRNAs determined 18 hpi with parental WT or M45mutRHIM virus (MOI of 10).
(B) Viability of SVEC4-10 cells using a subset of conditions described in (A).
(C) IB of 3T3-SA cells infected with parental WT or M45mutRHIM virus (MOI of 5), harvested at indicated times for IP of RIP3 followed by detection of vIRA (M45)
and RIP3. IB using 5% of cell lysate to detect vIRA (M45) and b-actin.
(D) IB of RIP3+/+, RIP3+/, and RIP3/ MEFs to detect RIP3, RIP1, and b-actin.
(E) Replication of WT and M45mutRHIM viruses (MOI of 5) on RIP3+/+ (left), RIP3+/ (middle), and RIP3/ (right) MEFs over a 72 hr time course. Viral titers were
determined by plaque assay with the first (0 h) time point representing the amount of virus in the inoculum.
(F) IB analysis for Flag-tagged proteins as well as b-actin (left) in RIP3/ MEFs expressing Flag-tagged RIP3, RIP3-KD, or RIP3-mRHIM, and viability of
reconstituted cells (right) infected with M45mutRHIM and WT virus.
(G) Viability of RIP3+/+, RIP3+/, and RIP3/ MEFs infected with WT or M45mutRHIM virus in the presence or absence of Nec-1 (30 mM).
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Virus Inhibition of RIP3-Dependent NecrosisMEFs as well as SVEC4-10 cells (Figures 4I and 4J), but these
failed to suppress virus-induced necrosis induced by indepen-
dently derived M45mutRHIM mutant viruses (Figures 4I and 4J).
Thus, unlike TNFa-induced necroptosis, virus-induced necrosis
relies on RIP3 but not RIP1.Normalization of M45 Mutant Virus Phenotype
in RIP3-Deficient Mice
Given that M45mutRHIM virus induced a form of RIP3-depen-
dent programmed necrosis that attenuates viral pathogenesis,
we inoculated RIP3/ and control mice to follow initial inflam-
matory events induced by mutant or parental virus. Footpad
inoculation allows assessment of virus-induced inflammation
at the site of inoculation, characterized by swelling of the footpad
compared with uninfected controls, which is influenced by the
MCMV-encoded CC chemokine homolog MCK-2 (Saederup
et al., 2001). M45mutRHIM virus infection induced swelling in
RIP3/ mice comparable to parental virus infection of either
RIP3+/+ or RIP3/ mice, reaching a greater than 50% increase
in size over uninfected paws (Figure 5A). In contrast, mutant virus
did not induce significant swelling in RIP3+/+ mice, consistent
with an attenuated phenotype. Thus, in the absence of RIP3
function, mutant virus infection recapitulated early inflammatory
events characteristic of WT infection.
TRIF is known to influence WT MCMV infection (Tabeta et al.,
2004). Given the importance of RHIM-mediated activity in sup-
pressing virus-induced death as well as the observation that
RIP3 associates with TRIF, we evaluated any role of this cellular
RHIM adaptor (Kaiser and Offermann, 2005; Meylan et al., 2004).
Despite previous demonstration that vIRA suppresses RHIM-
dependent cell-death signaling relayed via TRIF (Upton et al.,
2008), footpad-inoculated TrifLps2/Lps2 mice (Hoebe et al., 2003)
failed to exhibit any difference in behavior from WT mice
(Figure 5A). When explanted RIP3+/+, RIP3/, and TrifLps2/Lps2
peritoneal exudate cells (PECs) were infected ex vivo with either
mutant or parental virus, only RIP3/ PECs were resistant to
mutant virus-induced programmed necrosis (Figure 5B).
Because PECs express TLR3 and TLR4, this experiment
excluded any contribution of TRIF-dependent TLR signaling to
virus-induced necrosis. Thus, vIRA plays a critical RIP3-depen-
dent, TRIF-independent step in viral pathogenesis.
Finally, we sought to evaluate the role of RIP3 in viral pathogen-
esis. SGs are the major site of secondary MCMV replication
and source of transmission between hosts. Virus levels in this
organ remain a sensitive indicator of successful infection and
dissemination to secondary organs in the host. Parental MCMV
disseminated at similar levels to SGs of control, RIP3/, and
TRIF-defective C57BL/6 mice. Consistent with experiments in
NSG and BALB/c mice, C57BL/6 mice failed to support infection
and dissemination of mutant virus, and this characteristic was
sharedwith TRIF-defectivemice (Figure 5C).Mutant andparental
virus titers in SGs of RIP3/mice were comparable (Figure 5C).
In the absence of RIP3, vIRA function appears dispensable for(H) Viability of RIP3+/+ and RIP3/ MEFs treated to induce necroptosis as desc
(I) IB analysis for RIP1 as well as b-actin (top), and viability (bottom) of WT (RIP3
determined for cells infected with WT or either of two independent isolates of M
(J) IB analysis (top) and viability (bottom) of SVEC4-10 cells using a subset of co
Error bars indicate SD of the mean. See also related Figure S3.
CellWT levels of viral replication or dissemination. Normalization of
mutant virus behavior by elimination of a host determinant
provides compelling evidence that RIP3 is the target of vIRA-
mediated modulation during MCMV infection, and suggests
RHIM-dependent vIRA suppression of RIP3 function in virus-
associated cell death is essential for MCMV pathogenesis.DISCUSSION
Manipulation of host cytokine and cell-death pathways affords
pathogens the opportunity to maintain an environment neces-
sary for efficient replication to establish a foothold within the
host organism. In this work, we demonstrate a critical role for
RIP3 as a positive regulator of a cell-intrinsic antiviral pro-
grammed necrosis triggered during MCMV infection. Our results
show a dependence on RIP3 function in both virus-associated
programmed necrosis and DR-associated necroptosis. We
also provide a clear mechanistic distinction between these two
pathways. Whereas necroptosis is dependent on a RIP1-RIP3
signaling complex (Cho et al., 2009; He et al., 2009; Zhang
et al., 2009), virus-induced death is dependent on RIP3 but inde-
pendent of RIP1. MCMV-encoded vIRA suppresses either
necrotic death pathway in a RHIM-dependent fashion, suggest-
ing the common target of this viral cell-death suppressor is RIP3.
The dramatic differences in behavior of viruses expressingWT or
RHIM-deficient form of vIRA, assayed in vitro and in vivo,
demonstrate this cell-death suppressor is critical for MCMV
replication and pathogenesis. Normalization of mutant virus
behavior when RIP3 function is eliminated in the host formally
establishes the biological target of suppression as well as the
significance of vIRA-RIP3 interactions. By revealing the com-
mitment of a specific pathogen-encoded suppressor to necrotic
death pathways, our data validate RIP3-dependent pro-
grammed necrosis as a central player in host defense and
strongly argues that RIP3 may be the dominant adaptor control-
ling cellular necrotic pathways in viral pathogenesis.
Restoration of an attenuated vIRA viral mutant phenotype
in vivo by the elimination of the host intracellular adaptor such
as RIP3 has rarely been achieved in studies on viral pathogen-
esis. The most relevant to our studies is the demonstration that
herpes simplex virus ICPg34.5 uniquely targets PKR (Leib
et al., 2000), an RNA binding adaptor protein that restricts trans-
lation in virus-infected cells. The attenuation of ICPg34.5 mutant
virus was completely normalized in PKR-deficient mice. Here
we provide in vivo evidence that the MCMV M45 gene product
vIRA mediates its biological function by antagonizing the host
pronecrotic kinase RIP3 via RHIM-mediated interactions. Thus,
our demonstration that virus carrying RHIM-deficient vIRA
exhibited normalized replication in RIP3-deficient mice demon-
strates the exclusive interplay of RIP3 and vIRA in MCMV
pathogenesis.
High levels of RIP3 remain the common feature predicting
sensitivity to either virus- or DR-induced necrotic death. Recentribed in Figure 2H in the presence or absence of Nec-1 (30 mM).
+/+) MEFs stably expressing Sc, RIP1-A, or RIP1-B shRNAs. Cell viability was
45mutRHIM virus.
nditions applied in (I).
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Figure 5. M45mutRHIM Attenuation In Vivo Is Specifically Normalized in RIP3-Deficient Mice
(A) Swelling induced by parental WT or M45mutRHIM virus infection of C57BL/6 (RIP3+/+),RIP3/, and TRIF-deficient (Lps2/Lps2) mice. Groups of five (C57BL/6
and RIP3/) or three (Lps2/Lps2) mice were inoculated (106 pfu) in footpads, thickness was measured with a digital caliper (Saederup et al., 2001), and mean
values were plotted at the indicated times over a 14 day time course. Error bars indicate standard error of the mean.
(B) Viability of explanted, cultured RIP3/, Lps2/Lps2, or C57BL/6 (WT) PECs at 18 hpi with either WT or M45mutRHIM. Error bars indicate SD of the mean.
(C) SGs were harvested from euthanized mice (described in A) and titers were determined by plaque assay. Each symbol represents one mouse, and solid
horizontal lines represent the mean for each group. The dotted line is the limit of detection in this assay.
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Virus Inhibition of RIP3-Dependent Necrosisfindings that high RIP3 levels confer sensitivity of human and
murine cell lines to TNFa-induced necroptosis (He et al., 2009;
Zhang et al., 2009) are entirely consistent with the results pre-
sented here. One characteristic of necroptosis, the requirement
of RIP1 kinase activity (Declercq et al., 2009; Festjens et al.,
2007), distinguishes this necrotic pathway from virus-induced
necrosis. Nec-1 treatment inhibits the formation of a RIP1-RIP3
complex, RIP3 activation, and cell death in response to TNFa
(Cho et al., 2009; He et al., 2009), but treatment with this
RIP1-specific inhibitor has no impact on virus-induced necrosis.
Overexpression of RIP3 has previously been reported to induce
cell death, including situations where RIP1 expression has been
eliminated (Zhang et al., 2009). Although this work indicated
RIP3 alone may be sufficient to drive necrotic death, the data
reported here show physiological relevance of a RIP3-depen-
dent, RIP1-independent pathway.
Althoughwe have identifiedRIP3 as the executioner ofMCMV-
induced programmed necrosis, the cellular processes leading to
activation of this pathway by virus remain unidentified. UV-inac-310 Cell Host & Microbe 7, 302–313, April 22, 2010 ª2010 Elsevier Intivated mutant virus does not induce cell death (Brune et al.,
2001), and preliminary evaluation suggests that inhibition of viral
DNA replication fails to protect fromprogrammednecrosis. Thus,
the RIP3-activating step likely originates from early events in
virus-infected cells, perhaps through cellular processes altered
or usurped by viral infection. Alternatively, PRRs initiate signals
to contend with pathogens, and several of these sensor proteins
are known to recruit RIP3. TLR3-TRIF contributes to the innate
immune response toMCMV infection (Hoebe et al., 2003; Tabeta
et al., 2004), and RIP3 binds to TRIF in a RHIM-dependent inter-
action (Kaiser and Offermann, 2005; Meylan et al., 2004),
although the significance of this interaction remains unclear.
The capacity of vIRA to suppress RHIM-dependent death signals
relayed via TRIF (Upton et al., 2008) was not sustained here, as
TRIF-deficient cells remained susceptible to killing by mutant
virus and mice lacking TRIF were no more susceptible to mutant
virus than were WT mice. Thus, suppression of programmed
necrosis by vIRA during infection is unlikely to involve TRIF
signaling. Our results raise the possibility that another sensorc.
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Virus Inhibition of RIP3-Dependent Necrosispathway drives RIP3 activation, and the IFN-inducible, cytosolic
DNA sensor DAI/ZBP1/DLM-1 (Takaoka et al., 2007) remains an
attractive candidate to fulfill such a role, given that it is both a
RHIM-containing adaptor and binding partner of RIP3 as well
as vIRA (Kaiser et al., 2008; Rebsamen et al., 2009). Defining
the cellular processes required for induction of RIP3-dependent
death during MCMV infections remains a significant future line
of investigation.
Cytomegaloviruses encode an array of cell-death suppressors
to counter apoptotic cell-death pathways that may dominate
in different cell and tissue settings (McCormick, 2008). MCMV
encodes three genes that target core components of the
apoptotic machinery: viral mitochondrial inhibitor of apoptosis,
vMIA (Goldmacher et al., 1999; McCormick et al., 2005), viral
inhibitor of Bak oligomerization, vIBO (Cam et al., 2010), and viral
inhibitor of caspase-8 activation, vICA (Skaletskaya et al., 2001).
Together, these functions antagonize caspase-dependent death
pathways that would otherwise compromise viral replication.
A recombinant viral mutant lacking the Bax inhibitor vMIA
replicates comparably to parental virus in visceral organs of
infected animals, but is attenuated for leukocyte-dependent
dissemination of virus to the SGs (Manzur et al., 2009). Mutants
lacking the caspase-8 inhibitor vICA are attenuated in vivo
following systemic inoculation, and are severely attenuated for
dissemination to SGs (Cicin-Sain et al., 2008). These results
support the importance of modulating host apoptotic pathways
in MCMV pathogenesis. It is worth noting that the attenuation of
vIRA mutants in vivo is as critical to viral pathogenesis as the
suppression of Bax activation or caspase-8 activation by vMIA
or vICA, respectively.
Conclusions
The identification of vIRA as an inhibitor of RIP3-dependent
programmed necrosis in a natural biological setting extends
the role of RIP3 as a vital player in host antiviral defense, and
underscores the critical role of vIRA RHIM-dependent activities
in suppression of programmed necrosis in MCMV pathogenesis.
This study also begins to illustrate the balance of necrotic and
apoptotic pathways in host defense against viruses, supporting
the growing evidence that viruses exploit multiple innate immune
processes to influence a wide range of alternative immune
effector activities.
EXPERIMENTAL PROCEDURES
Reagents
CHX,BafilomycinA1, and dimethyl sulfoxide (DMSO)were fromSigma-Aldrich.
Nec-1 and z-VAD-fmk were from Calbiochem and Enzo Life Sciences, respec-
tively. Recombinantmouse TNFawas fromPeproTech andanti-TNFaantibody
was from R&D Systems. The following antibodies were used in IB analyses:
mouse anti-b-actin (clone AC-74; Sigma), mouse anti-RIP1 (clone 38; BD
Biosciences), rabbit anti-RIP3 (Imgenex), rabbit anti-cleaved caspase-3 (Cell
Signaling Technology), rabbit anti-LC3B (Cell Signaling Technology), mouse
anti-Flag (M2 clone) horseradish peroxidase (HRP) conjugate (Sigma-Aldrich),
mouse anti-c-myc (clone 9E10; Sigma-Aldrich), rabbit anti-c-myc HRP conju-
gate (Sigma-Aldrich), anti-mouse IgG-HRP (Vector Laboratories), anti-rabbit
IgG-HRP (Vector Laboratories), anti-MCMV M45 (gift from David Lembo,
University of Turin), and anti-MCMV IE1 (gift from Stipan Jonjic, University of
Rijeka). IP analyses were performed with rabbit anti-c-myc agarose conjugate
(Sigma-Aldrich) or goat anti-RIP3 (clone C-16; Santa Cruz Biotechnology) and
protein A/G agarose (Santa Cruz Biotechnology).CellBAC Mutagenesis and Recombinant Viruses
Plasmid pSIM6 encoding l red recombination functions (Datta et al., 2006)
was introduced into bacteria carrying a bacterial artificial chromosome
(BAC) harboring the MCMV K181(Perth) strain genome (Redwood et al.,
2005). Recombineering for K181-BAC mutagenesis and diagnostics were
performed essentially as previously described (Tandon and Mocarski, 2008),
and is outlined in Supplemental Information. BAC-derivedmutant and parental
K181 virus was generated in NIH 3T3 fibroblasts (CRL-1658; American Type
Culture Collection) and purified as previously described (Redwood et al.,
2005). Parental and mutant viruses were propagated, clarified, concentrated,
and titered by plaque assay on NIH 3T3s as previously described (Saederup
et al., 1999). Growth curves and viral yields were performed by infecting cells
in six-well plates at the indicated multiplicity of infection (MOI) in 0.5 ml for 2 hr
at 37C with periodic rocking. Following adsorption, cells were washed three
times with PBS and refed. Samples were harvested at indicated times, and
titered by plaque assay.
Mice, Infections, and Organ Harvests
C57BL/6, BALB/c, TRIF mutant (strain C57BL/6J-Ticam1Lps2) (Hoebe et al.,
2003), and NSG mutant (NOD.cg-PrkdcscidIl2rgtm1Wjl/Sz) (Shultz et al., 2005)
mice were from Jackson Laboratory. RIP3/ mice (Newton et al., 2004)
were provided by Francis Chan (University of Massachusetts) with permission
from Genentech. Eight- to twelve-week-old mice were inoculated with 106 pfu
into a rear footpad or by intraperitoneal injection as previously described
(Saederup et al., 1999). Upon sacrifice, organs were placed in 1 ml complete
DMEM and stored at 80C until they were thawed, disrupted by sonication,
and titered by plaque assay. Resident peritoneal macrophages were collected
as previously described (Saederup et al., 1999) and seeded at a density of 53
104 cells per well in 96-well plates 18 hr prior to infection. For virulence
studies, animals losing 20% body weight or displaying severe signs of CMV
disease (ruffled fur, hunched posture, dehydration, diminished responsive-
ness) were scored and euthanized. Mice were bred and maintained by the
Emory University Division of Animal Resources, where all procedures were
approved by the Emory University Institutional Animal Care and Use
Committee.
Cell Culture and Embryonic Fibroblast Isolation
NIH 3T3 fibroblasts, 3T3-SA (ATCC CCL-92), SVEC4-10 (ATCC CRL-2181),
HEK293T, L929, and MEFs were maintained in DMEM containing 4.5 g/ml
glucose, 10% fetal bovine serum (Atlanta Biologicals), 2 mM L-glutamine,
100 U/ml penicillin, and 100 U/ml streptomycin (Invitrogen). SV40T-trans-
formed RIP1/ and control WT MEFs (Wong et al., 2010) were provided by
John Silke (LaTrobe University) with permission fromMichelle Kelliher (Univer-
sity of Massachusetts). MEFs were isolated from timed pregnancies at days
E14.5–16.5, as previously described (Pollock and Virgin, 1995).
Immunoblot and Immunoprecipitations
IPs were performed essentially as described previously (Kaiser and Offer-
mann, 2005), with minor modifications. Clarified cell lysates were incubated
overnight with anti-c-myc agarose or goat-anti-RIP3 antibody and protein
A/G agarose and were washed four to six times prior to analysis. Cell lysates
and IP samples were separated on Criterion gels (Bio-Rad), transferred to
Immobilon PVDF membranes (Millipore), and subjected to IB analysis.
Detection of c-myc and RIP3 immunoprecipitates was performed with mouse
anti-c-myc (clone 9E10) or rabbit anti-RIP3 antibodies, respectively.
Plasmids, Transfections, and Transductions
Transfectionswereperformedwith Lipofectamine 2000 (Invitrogen) andDNAat
a 1:1 ratio inOpti-MEM (Invitrogen). Carboxy-terminal Flag-epitope-taggedWT
andmutRHIMM45were generated by subcloning the respective open reading
frame into pCMV-TAG4A (Stratagene). pCMV10-3xFlag-RIP3 and pcDNA3-
6myc-RIP1 (Kaiser and Offermann, 2005) have been previously described.
Flag-RIP3, Flag-RIP3-KD (Kaiser et al., 2008), and Flag-RIP3-mRHIM (Kaiser
and Offermann, 2005), as well as M45-myc and M45mutRHIM-myc (Upton
et al., 2008) were subcloned into the pQCXIH (Clontech) retroviral construct.
The pLKO.1-based RIP3-A (TRCN0000022535), RIP3-B (TRCN0000022538),
RIP1-A (TRCN0000022467), and RIP1-B (TRCN0000022464) shRNA con-
structs were obtained from Open Biosystems. The pLKO.1-scramble controlHost & Microbe 7, 302–313, April 22, 2010 ª2010 Elsevier Inc. 311
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Virus Inhibition of RIP3-Dependent NecrosisshRNAvector (Sarbassov et al., 2005) aswell as lentiviral and retroviral produc-
tion, infection, and selection have all been described (Kaiser et al., 2008).
Cell Viability Assays
Cells (5000 cells/well) were seeded into 96-well plates. Sixteen to eighteen
hours postseeding, medium was replaced with 50 ml of viral inoculum contain-
ing 10 pfu/cell (MOI = 10.0). Nec-1 at the indicated concentration was added 1
hr prior to infection, and maintained for the duration of the assay. Alternatively,
cells were treated with TNFa, CHX, zVAD-fmk, and/or Nec-1. The Nec-1
vehicle, DMSO, was held constant for all cells. Viability was determined
18 hr postinfection/treatment. Unless otherwise indicated, the number of
viable cells per well was determined indirectly by measuring the intracellular
levels of ATP using the Cell Titer-Glo Luminescent Cell Viability Assay kit
(Promega) according to the manufacturer’s instructions. Released protease
activity wasmeasured using the CytoTox-Fluor Assay kit (Promega) according
to the manufacturer’s instructions. Luminescence or fluorescence was
measured on a Synergy HT Multi-Detection microplate reader (Bio-Tek).
Microscopy
3T3-SA cells were infected withWT orM45mutRHIM viruses (MOI of 10) for the
indicated times in 6- or 12-well dishes. Bright-field images were acquired with
an AxioCam MRC5 camera with Zeiss Axio Imager A1 and processed with
AxioVision Release 4.5 software. 3T3-SA cells infected with WT or M45mutR-
HIM viruses (MOI of 10) for 18 hr were prepared for EM as described (Tandon
and Mocarski, 2008).
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and three figures and can be found with this article online at doi:10.1016/
j.chom.2010.03.006.
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